Reynders McVeigh Capital Management, LLC

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 13, 2024
Value $
$1.76B
Signature - Title
Kevin Fairweather - Controller
Location
10 Post Office Square, Suite N1010, Boston, MA
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 198 $1.76B +$240M -$118M +$123M NVDA, AAPL, MSFT, MA, CARR 13F-HR 8/13/2024, 01:43 PM
Q1 2024 199 $1.74B +$67.7M -$51.9M +$15.9M NVDA, AAPL, MSFT, MA, NVO 13F-HR 5/7/2024, 04:23 PM
Q4 2023 195 $1.58B +$64.9M -$81.1M -$16.2M AAPL, NVDA, MSFT, MA, ROK 13F-HR 2/7/2024, 04:37 PM
Q3 2023 195 $1.46B +$60.9M -$48.3M +$12.6M AAPL, NVDA, MSFT, MA, ROK 13F-HR 11/9/2023, 11:31 AM
Q2 2023 206 $1.53B +$32.1M -$55.1M -$22.9M AAPL, NVDA, ROK, MSFT, MA 13F-HR 8/9/2023, 10:59 AM
Q1 2023 203 $1.45B +$23.2M -$59.8M -$36.6M AAPL, ROK, ADI, NVDA, MA 13F-HR 5/3/2023, 11:45 AM
Q4 2022 210 $1.36B +$24.4M -$56.4M -$32M AAPL, DHR, MA, ROK, ADI 13F-HR 2/10/2023, 03:22 PM
Q3 2022 207 $1.29B +$102M -$24.8M +$77.6M AAPL, DHR, MA, MSFT, ROK 13F-HR 11/8/2022, 02:14 PM
Q2 2022 218 $1.33B +$51.2M -$32.9M +$18.3M AAPL, DHR, MA, MSFT, ADI 13F-HR 8/5/2022, 02:07 PM
Q1 2022 230 $1.64B +$55.7M -$43.1M +$12.7M AAPL, DHR, NVDA, MSFT, MA 13F-HR 5/11/2022, 04:21 PM
Q4 2021 239 $1.76B +$30.1M -$33.7M -$3.54M AAPL, DHR, NVDA, ROK, MSFT 13F-HR 2/11/2022, 03:34 PM
Q3 2021 222 $1.63B +$72.3M -$25M +$47.3M AAPL, DHR, PYPL, ROK, MA 13F-HR 11/15/2021, 05:27 PM
Q2 2021 232 $1.63B +$42.3M -$34.4M +$7.89M AAPL, PYPL, DHR, MA, ROK 13F-HR 8/12/2021, 02:23 PM
Q1 2021 229 $1.5B +$79.4M -$57.3M +$22.1M AAPL, PYPL, MA, DHR, DIS 13F-HR 5/7/2021, 12:16 PM
Q4 2020 222 $1.46B +$43.8M -$47.1M -$3.36M AAPL, PYPL, MA, DHR, DIS 13F-HR 2/10/2021, 04:41 PM
Q3 2020 224 $1.3B +$129M -$27.9M +$101M AAPL, MA, DHR, PYPL, NKE 13F-HR 10/28/2020, 01:28 PM
Q2 2020 209 $1.14B +$83.8M -$27.3M +$56.5M AAPL, MA, PYPL, DHR, ROK 13F-HR 8/14/2020, 03:06 PM
Q1 2020 193 $878M +$39.7M -$57.5M -$17.8M AAPL, MA, DHR, TDOC, ABT 13F-HR 5/13/2020, 01:26 PM
Q4 2019 228 $1.04B +$44.6M -$22.5M +$22.1M AAPL, MA, DIS, DHR, ROK 13F-HR 2/14/2020, 02:16 PM
Q3 2019 224 $937M +$27.1M -$20.2M +$6.91M MA, AAPL, DHR, DIS, SYK 13F-HR 11/8/2019, 03:56 PM
Q2 2019 213 $932M +$19.5M -$35.8M -$16.3M MA, AAPL, DIS, DHR, PYPL 13F-HR 8/6/2019, 04:21 PM
Q1 2019 210 $904M +$46.5M -$18.8M +$27.7M MA, AAPL, DHR, PYPL, NVS 13F-HR 5/10/2019, 02:26 PM
Q4 2018 206 $754M +$34.3M -$24.3M +$10M MA, AAPL, JNJ, DIS, NVS 13F-HR 2/14/2019, 04:21 PM
Q3 2018 201 $851M +$20M -$31.2M -$11.2M AAPL, MA, JNJ, ILMN, DIS Restatement 11/26/2018, 11:37 AM
Q2 2018 203 $784M +$38.6M -$66.5M -$27.9M MA, AAPL, JNJ, DIS, GOOGL 13F-HR 8/9/2018, 03:05 PM
Q1 2018 197 $791M +$59.8M -$25M +$34.7M MA, AAPL, JNJ, XYL, NVS Restatement 7/26/2018, 03:37 PM
Q4 2017 202 $763M +$15.1M -$63.5M -$48.4M AAPL, PG, MA, JNJ, ROK 13F-HR 2/6/2018, 05:18 PM
Q3 2017 212 $767M +$27.6M -$40.4M -$12.8M PG, AAPL, MA, ROK, JNJ 13F-HR 11/9/2017, 05:01 PM
Q2 2017 222 $747M +$27.3M -$38.5M -$11.2M PG, AAPL, JNJ, CVS, ROK 13F-HR 8/14/2017, 04:23 PM
Q1 2017 223 $728M +$40.1M -$58.7M -$18.6M PG, AAPL, JNJ, CVS, ROK 13F-HR 4/27/2017, 01:02 PM
Q4 2016 225 $704M +$37M -$19M +$17.9M PG, CVS, AAPL, JNJ, ROK 13F-HR 2/14/2017, 11:04 AM
Q3 2016 211 $686M +$45M -$67.2M -$22.2M PG, CVS, AAPL, JNJ, NVS 13F-HR 11/7/2016, 03:11 PM
Q2 2016 218 $689M +$57M -$42.8M +$14.2M CVS, PG, JNJ, NVS, ROK 13F-HR 8/3/2016, 05:40 PM
Q1 2016 220 $676M +$105M -$45.4M +$60M CVS, PG, JNJ, MA, AAPL 13F-HR 5/13/2016, 02:44 PM
Q4 2015 201 $610M +$76.5M -$66.2M +$10.3M CVS, PG, MA, NVS, ADP 13F-HR 2/16/2016, 02:55 PM
Q3 2015 201 $574M +$48.7M -$23.6M +$25.1M CVS, PG, NVS, MA, ADP 13F-HR 11/10/2015, 03:30 PM
Q2 2015 204 $612M +$62.5M -$23.3M +$39.2M CVS, PG, NVS, JCI, MA 13F-HR 8/12/2015, 03:31 PM
Q1 2015 173 $582M +$59.4M -$50.7M +$8.68M CVS, PG, NVS, JCI, ADP 13F-HR 5/8/2015, 05:30 PM
Q4 2014 170 $570M +$32.8M -$21.9M +$10.9M CVS, PG, NVS, JCI, JNJ 13F-HR 2/6/2015, 09:27 PM
Q3 2014 163 $526M +$102M -$11.7M +$89.8M CVS, PG, NVS, JNJ, ADP Restatement 11/7/2014, 10:36 AM
Q2 2014 163 $439M +$38.6M -$27M +$11.6M CVS, PG, JCI, JNJ, NVS 13F-HR 8/11/2014, 01:11 PM
Q1 2014 161 $422M +$29.1M -$12.4M +$16.6M PG, CVS, JCI, JNJ, NVS 13F-HR 5/12/2014, 09:02 AM
Q4 2013 157 $404M $0 $0 PG, CVS, JCI, ADP, EMR 13F-HR 2/6/2014, 09:08 PM